Portal Hypertension in Children With Wilms' Tumor: A Report From the National Wilms' Tumor Study Group

International Journal of Radiation Oncology Biology Physics

Volumn 77, Issue 1, 2010, Pages 210-216

  Warwick, Anne B ^a   Kalapurakal, John A ^b   Ou, San San ^c   Green, Daniel M ^d   Norkool, Pat A ^c   Peterson, Susan M ^c   Breslow, Norman E ^c,e  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c USA   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Chemotherapy; Late effects; Portal hypertension; Radiation therapy; Wilms' tumor

Indexed keywords

CASE-CONTROL STUDY; DOXORUBICIN; HAZARD RATIO; LATE EFFECTS; LOGISTIC REGRESSIONS; LOWER CONFIDENCE BOUND; MEDICAL RECORD; PORTAL HYPERTENSION; RADIATION THERAPY; RISK FACTORS; STUDY GROUPS; WILMS' TUMOR;

CHEMOTHERAPY; LIVER; PATIENT MONITORING; RADIATION EFFECTS; RADIOTHERAPY;

TUMORS;

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; LIVER TOXICITY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NEPHROBLASTOMA; PORTAL HYPERTENSION; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; RISK FACTOR;

ANTIBIOTICS, ANTINEOPLASTIC; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; HYPERTENSION, PORTAL; KIDNEY NEOPLASMS; LIVER; LOGISTIC MODELS; MALE; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY DOSAGE; RISK; SPLEEN; WILMS TUMOR;

EID: 77950585560     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.04.057     Document Type: Article

References (30)

1. Breslow N., Olshan A., Beckwith J., et al. Epidemiology of Wilms' tumor. Med Pediatr Oncol 21 (1993) 172-181
2. Stiller C.A., and Parkin D.M. International variations in the incidence of childhood renal tumours. Br J Cancer 62 (1990) 1026-1030
3. Grundy P.E., et al. Renal tumors. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 4th edition (2002), Lippincott, Williams & Wilkins, Philadelphia 865-893
4. Breslow N.E., Takashima J.R., Whitton J.A., et al. Second malignant neoplasms following treatment for Wilms' tumor--A report from the National Wilms' Tumor Study Group. J Clin Oncol 13 (1995) 1851-1859
5. Taylor A.J., Winter D.L., Pritchard-Jones K., et al. Second primary neoplasms in survivors of Wilms' tumor--A population-based cohort study from the British Childhood Cancer Survivor Study. Int J Cancer 122 (2008) 2085-2093
6. Evans A.E., Norkool P., Evans I., et al. Late effects of treatment for Wilms' tumor--A report from the National Wilms' Tumor Study Group. Cancer 67 2 (1991) 331-338
7. Green D.M., Grigoriev Y.A., Nan B., et al. Congestive heart failure after treatment for Wilms' tumor. A report from the National Wilms' Tumor Study Group. J Clin Oncol 19 7 (2001) 1926-1934
8. Schwartz C.L., Hobbie W.L., Constine L.S., and Ruccione K.S. Survivors of childhood cancer: Assessment and management (1994), Mosby, St. Louis
9. Samuels L.D. Paradoxical splenic enlargement following radiation therapy. Radiol 104 (1972) 389-391
10. Moore K.L. The portal vein and portal-systemic anastomoses. In: Satterfield T.S. (Ed). Clinical oriented anatomy: The Abdomen. 3rd edition (1992), Williams & Wilkins, Baltimore 209-210
11. Roback S.A., Nesbit M.E., Sharp H.L., et al. Portal Hypertension following surgery, x-radiation, and actinomycin D therapy of nephroblastoma. J Pediatr 78 6 (1971) 1031-1034
12. Barnard J.A., Marshall G.S., Neblett W.W., et al. Noncirrhotic portal fibrosis after Wilms tumor therapy. Gastroenterol 90 (1986) 1054-1056
13. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 456-481
14. Peto R., and Peto J. Asymptotically efficient rank invariant test procedures. J Royal Stat Soc (Series A) 135 (1972) 185-206
15. Langholz B., and Goldstein L. Risk set sampling in epidemiologic cohort studies. Stat Sci 11 (1996) 35-53
16. Cox D.R. Analysis of binary data (1970), Chapman & Hall, New York
17. CYTEL Software Corporation. StatXact 6 user manual (2003), CYTEL Software Corporation, Cambridge, MA
18. Reed Jr. G.B., and Cox A.J. The human liver after radiation injury-A form of veno-occlusive disease. Am J Pathol 48 4 (1966) 597-611
19. Tefft M., Mitus A., Das L., et al. Irradiation of the liver in children: Review of experience in the acute and chronic phases, and in the intact normal and partially resected. Am J Roentgenol 108 2 (1970) 365-385
20. Thomas P.R., Griffith K.D., Fineberg B.B., et al. Late effects of treatment for Wilms' tumor. Int J Radiat Oncol Biol Phys 9 5 (1983) 651-657
21. Tefft M., Traggis D., and Filler R.M. Liver irradiation in children: acute changes with transient leukopenia and thrombocytopenia. Am J Roentgenol 106 4 (1969) 750-765
22. Samuels L.D. Paradoxical splenic enlargement following radiation therapy. Radiology 104 2 (1972) 389-391
23. D'Angio G.J., Evans A.E., Breslow N., et al. The treatment of Wilms' tumor. Results of the National Wilms' Tumor Study. Cancer 38 2 (1976) 633-646
24. D'Angio G.J., Evans A.E., Breslow N., et al. The treatment of Wilms' tumor: Results of the second National Wilms' Tumor Study. Cancer 47 9 (1981) 302-311
25. D'Angio G.J., Breslow N., Beckwith J.B., et al. Treatment of Wilms' tumor. Results of the third National Wilms' Tumor Study. Cancer 64 2 (1989) 349-360
26. Sutow W.W., Breslow N.E., Palmer N.F., et al. Prognosis in children with Wilms' tumor metastases prior to or following primary treatment: results from the first National Wilms' Tumor Study (NWTS-1). Am J Clin Oncol 5 4 (1982) 339-347
27. Green D.M. The treatment of stages I-IV favorable histology Wilms' tumor. J Clin Oncol 22 8 (2004) 1366-1372
28. Green D.M., Breslow N.E., Beckwith J.B., et al. Comparison between single-dose and divided-dose administration of dactinomycin and doxorubicin for patients with Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 16 1 (1998) 237-245
29. Green D.M., Breslow N.E., Evans I., et al. The effect of chemotherapy dose intensity on the hematologic toxicity of the treatment for Wilms' tumor. A report from the National Wilms' Tumor Study. Am J Pediatr Hematol Oncol 16 3 (1994) 207-212
30. Grundy P.E., Breslow N.E., Li S., et al. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable histology Wilms' tumor. A report from the National Wilms' Tumor Study Group. J Clin Oncol 23 29 (2005) 7312-7321